Interestingly, both hCD4+ and hCD8+ T cells were isolated from the primary tumor sites, with CD4/CD8 average ratios of 0.9732 (responders) and 1.859 (non-responders) (Figure S3G). This evidence concerns the gene CD4 and neoplasm.